(Q53497088)

14 May 2018

title

NK resistance of tumor cells from multiple myeloma and chronic lymphocytic leukemia patients: implication of HLA-G. (English)

1 reference

14 May 2018

chronic lymphocytic leukemia

0 references

1 reference

1 reference

1 reference

5

E D Carosella

1 reference

14 May 2018

Nathalie Rouas-Freiss

6

object named as

N Rouas-Freiss

1 reference

14 May 2018

author name string

G Maki

1

1 reference

14 May 2018

G M Hayes

2

1 reference

14 May 2018

A Naji

3

1 reference

14 May 2018

T Tyler

4

1 reference

14 May 2018

S A Gregory

7

1 reference

14 May 2018

publication date

21 February 2008

1 reference

14 May 2018

published in

Leukemia

1 reference

14 May 2018

volume

22

1 reference

14 May 2018

issue

5

1 reference

14 May 2018

page(s)

998-1006

1 reference

14 May 2018

https://scigraph.springernature.com/pub.10.1038/leu.2008.15

exact match

0 references

cites work

The CD85/LIR-1/ILT2 inhibitory receptor is expressed by all human T lymphocytes and down-regulates their functions

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

Advances in biology of multiple myeloma: clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Novel therapeutic approaches for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Biology and treatment of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Hematopoietic stem cell transplantation in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Hematopoietic cell transplantation for chronic lymphocytic leukemia: an evolving concept

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Biology of natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

https://api.crossref.org/works/10.1038%2FLEU.2008.15

1 reference

7 January 2021

NK cell recognition of non-classical HLA class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Specificity and function of immunoglobulin superfamily NK cell inhibitory and stimulatory receptors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

NK cells, MHC class I molecules and the missing self

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Alloreactive killer cells: hindrance and help for haematopoietic transplants

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

HLA-G molecules: from maternal-fetal tolerance to tissue acceptance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

A class I antigen, HLA-G, expressed in human trophoblasts

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Uterine NK cells and trophoblast HLA class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

HLA-G proteins in cancer: do they provide tumor cells with an escape mechanism?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Trogocytosis-based generation of suppressive NK cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

High-sensitive immunophenotyping and DNA ploidy studies for the investigation of minimal residual disease in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

HLA-G class I gene expression in normal and malignant hematopoietic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Soluble HLA-G molecules are increased in lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Total Soluble HLA Class I and Soluble HLA-G in Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

A homodimeric complex of HLA-G on normal trophoblast cells modulates antigen-presenting cells via LILRB1.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.15

7 January 2021

Identifiers

DOI

10.1038/LEU.2008.15

1 reference

14 May 2018

1 reference

14 May 2018